Novo Nordisk Pushes on Two Fronts: Pill Adoption Surges as Implant Partnership Takes Shape
The Danish pharma giant is accelerating its assault on the obesity market from two distinct angles, pairing a…
Novo Nordisk Navigates Conflicting Signals as Wegovy Pill Surges But Employer Reimbursement Tightens
Oral Wegovy sets record US prescriptions while Cigna drops GLP-1 coverage; Goldman Sachs raises target but stays neutral;…
From Chatbots to Chemists: Novo Nordisk’s Wegovy Pill Surges as Canadian Generics Undercut Ozempic
Novo Nordisk’s Wegovy leads weight-loss drug search results on AI chatbots, but generic semaglutide enters Canadian pharmacies at…
Novo Nordisk’s Oral Wegovy Pill Surges Past Eli Lilly, but Generics and Price Pressure Loom
Novo Nordisk’s oral Wegovy pill leads Eli Lilly’s Foundayo 2-to-1 in US prescriptions, but faces generic competition in…
Novo Nordisk surges as Hims & Hers ditches copycat weight-loss pill
Shares of Danish pharmaceuticals firm Novo Nordisk surged on Monday after US telehealth company Hims & Hers said…